Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Arthritis care & research

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/acr.23188PMID 28085235PMCID PMC5509530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy

  2017cited by this paper
• Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity

  2016cited by this paper
• Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.

  2014cited by this paper
• Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset

  2014cited by this paper
• The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis

  2014cited by this paper
• Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

  2013cited by this paper
• An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

  2013cited by this paper
• Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

  2012cited by this paper
• Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

  2012cited by this paper
• Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis

  2009cited by this paper
• Autoantibodies to the p140 Autoantigen NXP-2 in Adult Dermatomyositis

  2009cited by this paper
• 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.

  2004cited by this paper
• Clinical and serological characterization of the anti-MJ antibody in childhood myositis

  1997cited by this paper
• Amyopathic dermatomyositis (dermatomyositis siné myositis). Presentation of six new cases and review of the literature.

  1991cited by this paper
• Polymyositis and dermatomyositis (first of two parts).

  1975cited by this paper

• Acute muscle injury and subcutaneous edema in a patient with anti-nuclear matrix protein-2 antibody positive dermatomyositis sine dermatitis: A Case Report.

  2026cites this paper
• Atypical dermatomyositis with positive anti-nuclear matrix protein 2 antibodies complicated by rhabdomyolysis syndrome: a case report and literature review.

  2026cites this paper
• Eculizumab as rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two cases.

  2025cites this paper
• Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all

  2025cites this paper
• Malignancy in Idiopathic Inflammatory Myopathies: Recent Insights

  2025influential citation
• [Anti-NXP2 antibody-positive dermatomyositis showing marked subcutaneous edema predominant in the upper limbs].

  2025cites this paper
• The feature and significance of lower limb MRI in adult myositis patients with anti-NXP2 antibody: a retrospective cohort study in China

  2025cites this paper
• Autoantibodies in Myositis: Can They Predict Disease Course?

  2025cites this paper
• A Novel Tool for Predicting Malignant Disease in Adult Patients With Dermatomyositis.

  2025cites this paper
• Critical Limb Ischaemia in a Patient With Subcutaneous Nodules: Clues to a Hidden Systemic Disease

  2025influential citation
• A Severe Case of Nuclear Matrix Protein-2-Positive Dermatomyositis With Negative Malignancy Workup

  2025influential citation
• Anti-Mi2 autoantibodies target the PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily recognize epitopes outside the PHD region of TIF1γ

  2025cites this paper
• Progressive course of anti-nuclear matrix protein-2 (NXP-2) positive-interstitial lung disease.

  2025cites this paper
• Risk, risk factors, and screening of malignancies in dermatomyositis: current status and future perspectives

  2025cites this paper
• NXP-2-positive dermatomyositis presenting with pronounced unilateral lower extremity subcutaneous edema

  2025cites this paper
• Dermatomyositis: A Narrative Review of Skin as a Window to Muscle and Malignancy

  2025influential citation
• Robot-assisted surgery for rectal cancer with tumor-associated dermatomyositis during preoperative chemotherapy: A case report and literature review

  2025cites this paper
• CD68 + macrophage infiltrations in muscle tissue of juvenile dermatomyositis associated with the course of the disease, not with the severity

  2025cites this paper
• Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region.

  2025cites this paper
• Anti‐nuclear matrix protein 2 antibody‐positive amyopathic dermatomyositis presenting in a patient with prostate cancer: A case report

  2024cites this paper
• An update on autoantibodies in the idiopathic inflammatory myopathies

  2024cites this paper
• Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles

  2024cites this paper
• Recent Updates on the Pathogenesis of Inflammatory Myopathies

  2024cites this paper
• Imaging Modalities in Myositis: A Clinical Review.

  2024cites this paper
• A Case of Vesiculobullous Dermatomyositis with Anti-NXP-2 Antibody without Malignancy.

  2024cites this paper
• NXP-2 positive dermatomyositis with marked dysphagia following an insect bite

  2024cites this paper
• Dermatomyositis, Antisynthetase-Syndrom und immunvermittelte nekrotisierende Myopathie

  2024cites this paper
• Gastrointestinal involvement in neuromuscular disorders

  2024cites this paper
• Anasarca and spontaneous intramuscular haemmorhage in a dermatomyositis patient: case report and review of the literature

  2024cites this paper
• [Juvenile-onset anti-nuclear matrix protein 2 (NXP-2) antibody-positive dermatomyositis with joint contractures before manifestation of myositis: a case report].

  2024cites this paper
• Autoantibody evaluation in idiopathic inflammatory myopathies.

  2024cites this paper
• Anasarca as the first presentation of anti-synthetase syndrome

  2024cites this paper
• A case of dermatomyositis induced by SARS-CoV-2 infection.

  2024cites this paper
• Dermatomyositis Presenting with Generalized Subcutaneous Edema

  2023cites this paper
• Dermatomyositis presenting with diffuse calcinosis

  2023cites this paper
• Cancer and idiopathic inflammatory myopathies –association of autoantibodies with carcinogenesis

  2023cites this paper
• Anti-NXP2 Antibody-positive Juvenile Dermatomyositis with Characteristic Fascial Thickening on Muscle Ultrasound and Improvement with Immunotherapy

  2023cites this paper
• Usefulness and Clinical Impact of Whole-Body MRI in Detecting Autoimmune Neuromuscular Disorders

  2023cites this paper
• [Two cases of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with severe diffuse subcutaneous edema and dysphagia].

  2023cites this paper
• A comprehensive review of dermatomyositis treatments - from rediscovered classics to promising horizons

  2023cites this paper
• Epidemiology of the idiopathic inflammatory myopathies

  2023cites this paper
• Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population

  2023influential citation
• Autoimmune disease, including Lupus Panniculitis in association with Panniculitic Cell Lymphomas.

  2023cites this paper
• Beyond skin and muscle: The unexplored territory of interstitial lung disease in anti‐NXP2‐positive myositis

  2023cites this paper
• Subcutaneous Edema in Polymyositis and Dermatomyositis

  2023cites this paper
• Comparison between of fuzzy partial H-transform and fuzzy partial Laplace transform in x-ray images processing of acute interstitial pneumonia

  2023cites this paper
• Myositis interstitial lung disease and autoantibodies

  2023influential citation
• Malignancy in dermatomyositis: a mono-centric retrospective study of 134 patients in China and a potential predictive model

  2023cites this paper
• Acute interstitial pneumonia image enhancement using fuzzy partial transforms

  2023cites this paper
• Expanding the clinical phenotype of nuclear matrix protein 2 antibody-positive dermatomyositis

  2023cites this paper
• Utility of Myositis-Specific Autoantibodies for Treatment Selection in Myositis

  2022cites this paper
• A rare presentation of rapidly progressing myopathy in an adolescent.

  2022cites this paper
• Edema localized to the lips as a novel manifestation of myositis

  2022cites this paper
• Assessment of Thigh MRI Radiomics and Clinical Characteristics for Assisting in Discrimination of Juvenile Dermatomyositis

  2022cites this paper
• Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study

  2022cites this paper
• Update on dermatomyositis

  2022cites this paper
• Inflammatory Myositis in a Child due to Anti-NXP2 Antibody, First Case Report from India

  2022cites this paper
• The Utility of Myositis Specific Antibodies in Clinical Practice.

  2022cites this paper
• Update on Paraneoplastic Neuromuscular Disorders

  2022cites this paper
• Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody–Positive Myositis: A Retrospective Cohort Study in China

  2022cites this paper
• Heliotrope Rash, Gottron Papules and Ragged Cuticles in Darker Skin.

  2022cites this paper
• Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis

  2022cites this paper
• A Rare Manifestation of a Rare Disease: The Importance of Thinking Outside the Box in a Patient With Complex Dermatomyositis

  2022cites this paper
• Myositis-specific Antibodies: Overview and Clinical Utilization

  2022cites this paper
• Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital

  2022cites this paper
• Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis

  2022cites this paper
• Anti-nuclear Matrix Protein 2 Antibody-positive Dermatomyositis Associated with Cervical Cancer Recurrence after 6 Years of Stable Disease

  2022influential citation
• Anti-nuclear matrix protein 2+ juvenile dermatomyositis with severe skin ulcer and infection: A case report and literature review

  2022cites this paper
• Cancer and myositis: Who, when, and how to screen.

  2022cites this paper
• Rapidly progressive interstitial pneumonia associated with anti-NXP2 antibody secondary to malignancy

  2022cites this paper
• Gastrointestinal Perforation in a Patient With Antinuclear Matrix Protein 2 Antibody–Positive Dermatomyositis

  2022cites this paper
• Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis

  2022influential citation
• An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations

  2022cites this paper
• Clinical features and diagnostic tools in idiopathic inflammatory myopathies

  2021cites this paper
• Response to: ‘Correspondence on ‘Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis’’ by Takanashi et al

  2021cites this paper
• Anti-nuclear matrix protein 2 antibody-positive idiopathic inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash

  2021influential citation
• Systematic review and meta analysis A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies

  2021cites this paper
• Anti-tRNA synthetase syndrome interstitial lung disease: A single center experience

  2021cites this paper
• Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody

  2021cites this paper
• [A case of dermatomyositis positive for anti-nuclear matrix protein 2 antibody without dermatologic symptoms].

  2021cites this paper
• Dermatomyositis autoantibodies: how can we maximize utility?

  2021influential citation
• Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis

  2021cites this paper
• In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests.

  2021cites this paper
• Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review

  2021cites this paper
• Prevalence of Nasopharyngeal Carcinoma in Patients with Dermatomyositis: A Systematic Review and Meta-Analysis

  2021cites this paper
• Diffuse esophageal involvement in anti-NXP2 myositis and response to combined immunosuppressive therapy.

  2021cites this paper
• Immune and Inflammatory Myopathies

  2021cites this paper
• Clinical Problem Solving: An Older Woman With Weakness from Head to Toe

  2021cites this paper
• The role of interferons type I, II and III in myositis: A review

  2021cites this paper
• Dermatomyositis

  2021cites this paper
• Inhibiting Interferon Pathways in Dermatomyositis: Rationale and Preliminary Evidence

  2021cites this paper
• Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.

  2021cites this paper
• Anti‐MJ/NXP‐2 antibody‐positive adult‐onset dermatomyositis with lichen myxedematosus and endometrial carcinoma

  2021cites this paper
• Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis

  2021cites this paper
• The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients

  2021cites this paper
• Refractory dermatomyositis which developed in a patient with silicone breast implants.

  2021cites this paper
• Diffuse Soft-Tissue Swelling in Antinuclear Matrix Protein-2 Antibody-Associated Dermatomyositis Sine Dermatitis.

  2021cites this paper
• Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis‐Specific Autoantibodies

  2021cites this paper
• [Anti-nuclear matrix protein 2 antibody-positive dermatomyositis with the preferential involvement of neck extensors: a case report].

  2021cites this paper
• Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.

  2021cites this paper